Sarah Furlong

Sarah Furlong is a female healthcare provider who helps people with Amyotrophic Lateral Sclerosis (ALS) and Primary Lateral Sclerosis. She has special skills in treating these conditions.

Sarah Furlong works closely with patients to understand their needs and provide the best care possible. She listens to their concerns and communicates in a way that makes them feel comfortable and supported. Patients trust her because she shows compassion and empathy in her interactions.

To stay updated with the latest medical knowledge, Sarah Furlong regularly reads research articles and attends conferences. This helps her provide the most effective treatments based on the newest information available.

Sarah Furlong values teamwork and collaboration with other medical professionals. She shares her knowledge and expertise with colleagues to improve patient outcomes. By working together, they can offer comprehensive care and support to those in need.

Sarah Furlong's dedication to her work has had a positive impact on many patients' lives. Her commitment to providing high-quality care and personalized treatment plans has helped improve the health and well-being of those she serves.

One of Sarah Furlong's notable publications is "Riluzole is associated with decreasing neuritic plaque severity in amyotrophic lateral sclerosis." This research, published in Brain: a journal of neurology, highlights her contributions to understanding and treating ALS.

In summary, Sarah Furlong is a caring and knowledgeable healthcare provider who goes above and beyond to support her patients and contribute to advancements in the field of neurology.